{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T13:27:44Z","timestamp":1773322064257,"version":"3.50.1"},"reference-count":25,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2011,10,1]],"date-time":"2011-10-01T00:00:00Z","timestamp":1317427200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2011,10]]},"DOI":"10.1016\/j.ijrobp.2010.05.065","type":"journal-article","created":{"date-parts":[[2010,10,2]],"date-time":"2010-10-02T04:41:49Z","timestamp":1285994509000},"page":"397-402","source":"Crossref","is-referenced-by-count":58,"title":["Comparison of Provider-Assessed and Patient-Reported Outcome Measures of Acute Skin Toxicity During a Phase III Trial of Mometasone Cream Versus Placebo During Breast Radiotherapy: The North Central Cancer Treatment Group (N06C4)"],"prefix":"10.1016","volume":"81","author":[{"given":"Michelle A.","family":"Neben-Wittich","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pamela J.","family":"Atherton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David J.","family":"Schwartz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeff A.","family":"Sloan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patricia C.","family":"Griffin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard L.","family":"Deming","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jon C.","family":"Anders","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles L.","family":"Loprinzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kelli N.","family":"Burger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James A.","family":"Martenson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert C.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2010.05.065_bib1","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/S1053-4296(03)00031-6","article-title":"CTCAE v3.0: Development of a comprehensive grading system for the adverse effects of cancer treatment","volume":"13","author":"Trotti","year":"2003","journal-title":"Semin Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2010.05.065_bib2","doi-asserted-by":"crossref","first-page":"5051","DOI":"10.1200\/JCO.2007.11.3324","article-title":"National Cancer Institute. Issues and challenges with integrating patient-reported outcomes in clinical trials supported by the National Cancer Institute\u2013sponsored clinical trials networks","volume":"25","author":"Bruner","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2010.05.065_bib3","doi-asserted-by":"crossref","first-page":"5070","DOI":"10.1200\/JCO.2007.12.7670","article-title":"National Cancer Institute. Integrating patient-reported outcomes into cancer symptom management clinical trials supported by the National Cancer Institute\u2013sponsored clinical trials networks","volume":"25","author":"Sloan","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2010.05.065_bib4","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1093\/jnci\/85.14.1138","article-title":"Assessing the reliability of two toxicity scales: Implications for interpreting toxicity data","volume":"85","author":"Brundage","year":"1993","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ijrobp.2010.05.065_bib5","first-page":"1187","article-title":"[Reliability at the National Cancer Institute-Common Toxicity Criteria version 2.0] [in Japanese]","volume":"31","author":"Kaba","year":"2004","journal-title":"Gan To Kagaku Ryoho"},{"key":"10.1016\/j.ijrobp.2010.05.065_bib6","doi-asserted-by":"crossref","first-page":"3552","DOI":"10.1200\/JCO.2005.04.275","article-title":"Patient online self-reporting of toxicity symptoms during chemotherapy","volume":"23","author":"Basch","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2010.05.065_bib7","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/0360-3016(85)90195-6","article-title":"Is cancer treatment toxicity accurately reported?","volume":"11","author":"Parliament","year":"1985","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2010.05.065_bib8","doi-asserted-by":"crossref","first-page":"5133","DOI":"10.1200\/JCO.2007.12.4644","article-title":"Patient-reported outcomes assessment in cancer trials: taking stock, moving forward","volume":"25","author":"Lipscomb","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2010.05.065_bib9","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1002\/1097-0142(19820901)50:5<893::AID-CNCR2820500515>3.0.CO;2-Y","article-title":"The palliation of symptomatic osseous metastases: Final results of the Study by the Radiation Therapy Oncology Group","volume":"50","author":"Tong","year":"1982","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2010.05.065_bib10","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.jpainsymman.2007.01.016","article-title":"Validation of single-item linear analog scale assessment of quality of life in neuro-oncology patients","volume":"34","author":"Locke","year":"2007","journal-title":"J Pain Symptom Manage"},{"key":"10.1016\/j.ijrobp.2010.05.065_bib11","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1016\/S0360-3016(01)02782-1","article-title":"Supportive use of megestrol acetate (Megace) with head\/neck and lung cancer patients receiving radiation therapy","volume":"52","author":"McQuellon","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2010.05.065_bib12","doi-asserted-by":"crossref","first-page":"2606","DOI":"10.1200\/JCO.2004.10.020","article-title":"Phase III, randomized, double-blind study of epoetin alfa compared with placebo in anemic patients receiving chemotherapy","volume":"23","author":"Witzig","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2010.05.065_bib13","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1002\/1097-0142(20001001)89:7<1634::AID-CNCR29>3.0.CO;2-V","article-title":"Assessing symptom distress in cancer patients: The M.D. Anderson Symptom Inventory","volume":"89","author":"Cleeland","year":"2000","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2010.05.065_bib14","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1016\/j.ijrobp.2003.09.100","article-title":"Quality of life as a survival predictor for esophageal squamous cell carcinoma treated with radiotherapy","volume":"58","author":"Fang","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2010.05.065_bib15","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.currproblcancer.2005.09.001","article-title":"Challenges in QOL assessment: Overview and introduction","volume":"29","author":"Sloan","year":"2005","journal-title":"Curr Probl Cancer"},{"issue":"Suppl. 2","key":"10.1016\/j.ijrobp.2010.05.065_bib16","doi-asserted-by":"crossref","first-page":"S59","DOI":"10.1111\/j.1524-4733.2007.00267.x","article-title":"Mayo\/FDA Patient-Reported Outcomes Consensus Meeting Group. The Mayo Clinic manuscript series relative to the discussion, dissemination, and operationalization of the Food and Drug Administration guidance on patient-reported outcomes","volume":"10","author":"Sloan","year":"2007","journal-title":"Value Health"},{"key":"10.1016\/j.ijrobp.2010.05.065_bib17","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1093\/jnci\/dji337","article-title":"Reflections on findings of the Cancer Outcomes Measurement Working Group: Moving to the next phase","volume":"97","author":"Gotay","year":"2005","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ijrobp.2010.05.065_bib18","unstructured":"Miller RC, Schwartz DJ, Sloan JA, et\u00a0al. Mometasone furoateeffect on acute skin toxicity in breast cancer patients receiving radiotherapy: A Phase 3 double-blind, randomized trial from the North Central Cancer Treatment Group N06C4. Int J Radiat Oncol Biol Phys. In press."},{"key":"10.1016\/j.ijrobp.2010.05.065_bib19","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1081\/BIP-120028507","article-title":"Issues for statisticians in conducting analyses and translating results for quality of life end points in clinical trials","volume":"14","author":"Sloan","year":"2004","journal-title":"J Biopharm Stat"},{"key":"10.1016\/j.ijrobp.2010.05.065_bib20","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.ijrobp.2007.06.022","article-title":"Effects of treatment intensification on acute local toxicity during radiotherapy for head and neck cancer: Prospective observational study validating CTCAE, version 3.0, scoring system","volume":"70","author":"Palazzi","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2010.05.065_bib21","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1002\/cncr.22444","article-title":"A pooled analysis of quality of life measures and adverse events data in north central cancer treatment group lung cancer clinical trials","volume":"109","author":"Huschka","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2010.05.065_bib22","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.jclinepi.2007.03.012","article-title":"Recommended methods for determining responsiveness and minimally important differences for patient-reported outcomes","volume":"61","author":"Revicki","year":"2008","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.ijrobp.2010.05.065_bib23","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/1477-7525-4-79","volume":"4","year":"2006","journal-title":"Health Qual Life Outcomes"},{"key":"10.1016\/j.ijrobp.2010.05.065_bib24","unstructured":"National Cancer Institute. Outcomesresearch. Cancer control and population sciences: Patient-reported outcomes version of the CTCAE (PRO-CTCAE) [updated September 28, 2009]. Available at: http:\/\/www.outcomes.cancer.gov\/tools\/pro-ctcae.html. Accessed December 23, 2009."},{"key":"10.1016\/j.ijrobp.2010.05.065_bib25","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/S1470-2045(06)70910-X","article-title":"Patient versus clinician symptom reporting using the National Cancer Institute Common Terminology Criteria for Adverse Events: Results of a questionnaire-based study","volume":"7","author":"Basch","year":"2006","journal-title":"Lancet Oncol"}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301610008163?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301610008163?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,7]],"date-time":"2018-12-07T12:23:42Z","timestamp":1544185422000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0360301610008163"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,10]]},"references-count":25,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,10]]}},"alternative-id":["S0360301610008163"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2010.05.065","relation":{},"ISSN":["0360-3016"],"issn-type":[{"value":"0360-3016","type":"print"}],"subject":[],"published":{"date-parts":[[2011,10]]}}}